abstract |
A medicinal agent useful for the treatment of hyperglycemia-related diseases, which comprises a combination of 3-(3-{4-[3-(ß-D-glucopyranosyloxy)-5-isopropyl-1H- pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2- dimethylpropionamide, which has an inhibitory activity on SGLT1 (sodium-dependent glucose cotransporter 1), or a pharmacologically acceptable salt thereof and an insulin-resistance-ameliorating agent. |